Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab, Oxaliplatin, and Capecitabine in Advanced Hepatocellular Carcinoma
NCT00483405Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Oct 2006
- Primary completion
- Feb 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in hepatocellular carcinoma (HCC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Oct 2006; status: completed.
02
Drugs
KL-140
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00483405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483405.